Geode Capital Management, LLC Dyne Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,307,604 shares of DYN stock, worth $41.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,307,604

Previous 932,838 40.17%

Holding current value

$41.7 Million

Previous $12.4 Million 199.23%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.06 - $29.18 $4.89 Million - $10.9 Million	374,766 Added 40.17%	1,307,604 $37.1 Million
Q4 2023 Feb 13, 2024	BUY	$6.62 - $13.64 $497,347 - $1.02 Million	75,128 Added 8.76%	932,838 $12.4 Million
Q3 2023 Nov 13, 2023	BUY	$8.6 - $12.18 $1.02 Million - $1.44 Million	118,524 Added 16.03%	857,710 $7.69 Million
Q2 2023 Aug 11, 2023	BUY	$8.53 - $14.28 $1.46 Million - $2.44 Million	170,664 Added 30.02%	739,186 $8.32 Million
Q1 2023 May 15, 2023	BUY	$10.88 - $15.0 $239,000 - $329,505	21,967 Added 4.02%	568,522 $6.55 Million

Q4 2022 Feb 13, 2023	BUY	$9.37 - $13.8 $121,229 - $178,544	12,938 Added 2.42%	546,555 $6.33 Million
Q3 2022 Nov 14, 2022	BUY	$7.2 - $15.17 $248,392 - $523,349	34,499 Added 6.91%	533,617 $6.78 Million
Q2 2022 Aug 12, 2022	BUY	$4.36 - $10.5 $44,977 - $108,318	10,316 Added 2.11%	499,118 $3.43 Million
Q1 2022 May 13, 2022	BUY	$6.52 - $12.27 $38,181 - $71,853	5,856 Added 1.21%	488,802 $4.71 Million
Q4 2021 Feb 11, 2022	BUY	$11.89 - $16.07 $801,647 - $1.08 Million	67,422 Added 16.23%	482,946 $5.74 Million
Q3 2021 Nov 12, 2021	BUY	$15.6 - $21.46 $13,681 - $18,820	877 Added 0.21%	415,524 $6.75 Million
Q2 2021 Aug 13, 2021	BUY	$15.94 - $22.33 $1.97 Million - $2.76 Million	123,751 Added 42.54%	414,647 $8.72 Million
Q1 2021 May 12, 2021	BUY	$14.0 - $29.3 $768,474 - $1.61 Million	54,891 Added 23.26%	290,896 $4.52 Million
Q4 2020 Feb 12, 2021	BUY	$16.81 - $23.94 $3.97 Million - $5.65 Million	236,005 New	236,005 $4.96 Million

Others Institutions Holding DYN

# of Institutions

176

Shares Held

87.1M

Call Options Held

130K

Put Options Held

209K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.65B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Dyne Therapeutics, Inc. Transaction History